2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Mortality: new trials by email Literature Review of Mortality trials Research Report on Mortality
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bezlotoxumab Yielded Outcomes by Addressing Personalized Needs in Clostridioides Difficile Infection Bezlotoxumab, Normal saline 0.9% or 5% dextrose water - Clostridioides Difficile Infection, Stool Microbiome | Phase 2 | Completed | Hellenic Institute for the Study of Sepsis | 44 | 2022-04-13 | 2026-03-04 |
| Prevention Of Nephrotoxicity Following Bone Marrow Transplantation Using Urodilatin and Mannitol URODILATIN (ULARITIDE, ATRIAL NATRIURETIC PEPTIDE), MANNITOL - Renal Dysfunction, Acute Renal Failure | Phase 2 | Completed | Rocky Mountain Cancer Centers | 20 | 2003-07-01 | 2008-06-03 |
Acute Kidney Injury (1) · Clostridium Infections (1) · Renal Insufficiency (1)
Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Gram-Positive Bacterial Infections (1) · Infections (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Urogenital Diseases (1) · Urologic Diseases (1)
Atrial Natriuretic Factor (1) · Mannitol (1) · Saline Solution (1) · Ularitide (1) · bezlotoxumab (1)
Hellenic Institute for the Study of Sepsis (1) · Rocky Mountain Cancer Centers (1)
Greece (1) · United States (1)
Chirag R Parikh, MD, PhD (1) · Evangelos J Giamarellos-Bourboulis, MD, PhD (1)